Role of dietary fatty acids in microglial polarization in Alzheimer's disease

Smita Eknath Desale1,2, Subashchandrabose Chinnathambi3,4

  • 1Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India.

Insights

Dietary omega-3 fatty acids can modulate microglial polarization, potentially reducing Tau protein propagation in Alzheimer's disease by promoting an anti-inflammatory phenotype.

Area of Science:

  • Neuroscience
  • Immunology
  • Nutrition

Background:

  • Microglial polarization is crucial in Alzheimer's disease (AD), impacting the brain environment through cell surface receptors and cytokine secretion.
  • Dietary lipids, particularly fatty acids, significantly influence microglial phenotype, receptor expression, and polarization.
  • Abnormal Tau protein phosphorylation and aggregation are key pathological hallmarks of AD, contributing to neuroinflammation and disease progression.

Purpose of the Study:

  • To investigate the role of dietary fatty acids in modulating microglial polarization.
  • To explore the potential of tuning microglia towards an anti-inflammatory phenotype in the context of Alzheimer's disease.
  • To hypothesize the impact of microglial phenotype modulation on Tau protein propagation.

Main Methods:

  • Review of existing literature on microglial polarization and dietary lipid influences.
  • Analysis of the relationship between fatty acid intake and microglial receptor expression.
  • Examination of Tau protein pathology and its interaction with neuroinflammation.

Main Results:

  • Omega-3 fatty acids demonstrate a significant influence on brain environments and glial cell phenotypes.
  • Dietary habits and fatty acid composition can fine-tune microglial inflammatory states by altering receptor expression.
  • Microglial polarization is a dynamic process influenced by external factors like diet.

Conclusions:

  • Modulating microglial polarization via dietary interventions, specifically omega-3 fatty acids, offers a potential therapeutic strategy for Alzheimer's disease.
  • Shifting microglia to an anti-inflammatory phenotype may inhibit the propagation of pathological Tau protein.
  • Understanding the interplay between diet, microglia, and neuroinflammation is vital for developing novel AD treatments.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
697
Inflammation01:38

Inflammation

Overview
61.2K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K